TABLE OF CONTENTS
|  |  |  | Volume 32, Issue 32 (August 2013) |  | In this issue
Review
Original Articles
Short Communication
Also new
   AOP
| |  |  |  | | Advertisement |  | Oncogenesis wants to publish YOUR paper.
Oncogenesis is indexed in PubMed, PubMed Central, and the Directory of Open Access Journals, ensuring maximum discoverability of your research. Author also benefit from: - Open access - Fast publication times - Easy online submission process - High exposure through Nature.com
Submit your paper today! | |
|
|  |  | Review | Top |  | Cells of origin for cancer: an updated view from prostate cancerL Xin Oncogene 2013 32: 3655-3663; advance online publication, November 26, 2012; 10.1038/onc.2012.541 Abstract | Full Text |  | Original Articles | Top |  | Immunobiology of human mucin 1 in a preclinical ovarian tumor modelR A Budiu, E Elishaev, J Brozick, M Lee, R P Edwards, P Kalinski and A M Vlad Oncogene 2013 32: 3664-3675; advance online publication, September 10, 2012; 10.1038/onc.2012.397 Abstract | Full Text |  |  |  | Recruitment of the tumour suppressor protein p73 by Kaposi’s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cellsS Santag, W Jäger, C B Karsten, S Kati, M Pietrek, D Steinemann, G Sarek, P M Ojala and T F Schulz Oncogene 2013 32: 3676-3685; advance online publication, September 10, 2012; 10.1038/onc.2012.385 Abstract | Full Text |  |  |  | Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cellsK C Lai, C J Liu, K W Chang and T C Lee Oncogene 2013 32: 3686-3697; advance online publication, September 17, 2012; 10.1038/onc.2012.384 Abstract | Full Text |  |  |  | TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behaviorS V Ivanov, A Panaccione, B Brown, Y Guo, C A Moskaluk, M J Wick, J L Brown, A V Ivanova, N Issaeva, A K El-Naggar and W G Yarbrough Oncogene 2013 32: 3698-3710; advance online publication, October 1, 2012; 10.1038/onc.2012.377 Abstract | Full Text |  |  |  | RBB, a novel transcription repressor, represses the transcription of HDM2 oncogeneC Xuan, Q Wang, X Han, Y Duan, L Li, L Shi, Y Wang, L Shan, Z Yao and Y Shang Oncogene 2013 32: 3711-3721; advance online publication, August 27, 2012; 10.1038/onc.2012.386 Abstract | Full Text |  |  |  | Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinomaN Kunkeaw, S H Jeon, K Lee, B H Johnson, S Tanasanvimon, M Javle, C Pairojkul, Y Chamgramol, W Wongfieng, B Gong, C Leelayuwat and Y S Lee Oncogene 2013 32: 3722-3731; advance online publication, August 27, 2012; 10.1038/onc.2012.382 Abstract | Full Text |  |  |  | Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermisV da Silva-Diz, S Solé-Sánchez, A Valdés-Gutiérrez, M Urpí, D Riba-Artés, R M Penin, G Pascual, E González-Suárez, O Casanovas, F Viñals, J M Paramio, E Batlle and P Muñoz Oncogene 2013 32: 3732-3743; advance online publication, September 3, 2012; 10.1038/onc.2012.375 Abstract | Full Text |  |  |  | Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stressR M Jones, O Mortusewicz, I Afzal, M Lorvellec, P García, T Helleday and E Petermann Oncogene 2013 32: 3744-3753; advance online publication, September 3, 2012; 10.1038/onc.2012.387 Abstract | Full Text |  |  |  | Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cellsM Chen, A R Bresnick and K L O'Connor Oncogene 2013 32: 3754-3764; advance online publication, September 10, 2012; 10.1038/onc.2012.383 Abstract | Full Text |  |  |  | Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity OpenS Chowdhry, Y Zhang, M McMahon, C Sutherland, A Cuadrado and J D Hayes Oncogene 2013 32: 3765-3781; advance online publication, September 10, 2012; 10.1038/onc.2012.388 Abstract | Full Text |  | Short Communication | Top |  | Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancerT Saandi, F Baraille, L Derbal-Wolfrom, A-L Cattin, F Benahmed, E Martin, P Cardot, B Duclos, A Ribeiro, J-N Freund and I Duluc Oncogene 2013 32: 3782-3788; advance online publication, September 17, 2012; 10.1038/onc.2012.401 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
|
|
No comments:
Post a Comment